المؤلفون: Bloem, LT, De Abreu Lourenço, R, Chin, M, Ly, B, Haas, M

مصطلحات الفهرس: colorectal cancer, mode of administration, patient involvement, treatment choice, text, Journal Article, Article

URL: http://handle.unsw.edu.au/1959.4/unsworks_59903
http://link.springer.com/article/10.1007/s40487-016-0020-4
https://orcid.org/0000-0002-9972-8119
https://orcid.org/0000-0002-9972-8119
Oncology and Therapy, 4, 1, 103-116

المؤلفون: Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Soman KV; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands; National Health Care Institute (ZIN), Diemen, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. Electronic address: l.t.bloem@uu.nl.

المصدر: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

المؤلفون: Sadreghaemy M; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Gamba MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.

المصدر: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5868.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Amoxicillin*/administration & dosage , Anti-Bacterial Agents*/administration & dosage , Suspensions*, Humans ; Netherlands ; Child, Preschool ; Infant ; Child ; Retrospective Studies ; Female ; Male ; Infant, Newborn ; Practice Patterns, Physicians'/statistics & numerical data ; Cohort Studies ; Pharmacies/statistics & numerical data ; Drug Prescriptions/statistics & numerical data ; Drug Packaging ; Databases, Factual

المؤلفون: Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands., van Hattem CC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands; National Health Care Institute (ZIN), Diemen, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl.

المصدر: Drug discovery today [Drug Discov Today] 2024 Jul; Vol. 29 (7), pp. 104031. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Ltd. Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5832 (Electronic) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Benzamides*/therapeutic use , Pyrimidines*/therapeutic use , Pyrimidines*/pharmacology, Humans ; Europe ; Indazoles/therapeutic use ; Pyrazoles/therapeutic use ; Decision Making ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Clinical Decision-Making ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology

المؤلفون: Madrid Paredes J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Versteeg JW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Vreman RA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jul; Vol. 116 (1), pp. 136-146. Date of Electronic Publication: 2024 Mar 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Technology Assessment, Biomedical*, Humans ; Europe ; Drug Approval ; Health Services Accessibility ; Off-Label Use/statistics & numerical data

المؤلفون: Jadoenathmisier KD; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Stoyanova-Beninska V; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Soons IM; National IT Institute for Healthcare (Nictiz), the Hague, the Netherlands., Leufkens HG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: l.t.bloem@uu.nl., Pasmooij AM; Dutch Medicines Evaluation Board, Utrecht, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

المصدر: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Nov 01; Vol. 202, pp. 106871. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

مواضيع طبية MeSH: Rare Diseases*/drug therapy , Orphan Drug Production* , European Union* , Terminology as Topic*, Humans ; Feasibility Studies ; Systematized Nomenclature of Medicine

المؤلفون: Ogar CK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Gilbert HN; Harvard Medical School, Department of Global Health and Social Medicine, USA., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Leopold C; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Bassi PU; Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria., Katagum YM; Department of Clinical Pharmacy & Pharmacy Administration, Bauchi State University, Gadau. Nigeria., Osakwe AI; A - Line Pharmaceutical, Nsukka, Enugu, State, Nigeria., Opadeyi AO; Department of Clinical Pharmacology and Therapeutics, College of Medical Sciences, University of Benin/University of Benin Teaching Hospital, Benin-City, Nigeria., Oreagba I; Department of Pharmacology, Therapeutics and Toxicology College of Medicine University of Lagos, Lagos, Nigeria., Mbo DND; Department of Internal Medicine, Maitama District Hospital, Abuja, Nigeria., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., De Bruin ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: M.L.deBruin@uu.nl.

المصدر: Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126196. Date of Electronic Publication: 2024 Aug 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Vaccines*/adverse effects , COVID-19 Vaccines*/administration & dosage , Patient Reported Outcome Measures* , Quality of Life* , COVID-19*/prevention & control , Vaccination*/adverse effects , Vaccination*/psychology, Humans ; Female ; Male ; Nigeria ; Adult ; Adolescent ; Young Adult ; Middle Aged ; SARS-CoV-2/immunology ; Surveys and Questionnaires ; Aged ; Vaccination Hesitancy/psychology ; Vaccination Hesitancy/statistics & numerical data

المؤلفون: Maksimova MV; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., van Thiel GJMW; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Tromp Y; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Lechner R; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, Netherlands., van Delden JJM; Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

المصدر: Frontiers in medicine [Front Med (Lausanne)] 2024 Jun 24; Vol. 11, pp. 1408553. Date of Electronic Publication: 2024 Jun 24 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

المؤلفون: Verweij S; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.; Unit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, Groningen University, Groningen, The Netherlands., Haverhoek V; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Bergman E; Swedish Medical Products Agency, Uppsala, Sweden., Westman G; Swedish Medical Products Agency, Uppsala, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Apr; Vol. 115 (4), pp. 871-880. Date of Electronic Publication: 2024 Feb 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Natural Language Processing* , Communication*, Humans ; Uncertainty ; European Union

المؤلفون: Verschueren MV; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. Electronic address: m.v.verschueren@uu.nl., Peters BJ; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Kruik VR; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands., Uitvlugt EB; Department of Clinical Pharmacy, OLVG, Amsterdam, Netherlands., Bijsmans AR; Department of Pulmonology, Maasstad Hospital, Rotterdam, Netherlands., Egberts AC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, Netherlands., van de Garde EM; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2024 Mar; Vol. 25 (2), pp. 119-127.e1. Date of Electronic Publication: 2023 Dec 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/pathology , Carcinoma, Squamous Cell*/drug therapy , Antibodies, Monoclonal, Humanized*, Humans ; B7-H1 Antigen/metabolism ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use